Heidi Schilter

Years Active: 2018-2022
Publications (10 Years): 2

Pharmaxis (Australia)

UNSW Sydney (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pharmaxis (Australia) Nov 01 2010

Australia

Senior Research Biologist :: Drug Discovery

Education History

UNSW Sydney Jul 01 2006 - Jul 01 2010

Australia

PHD :: Medicine

Publications

Alison Findlay, Craig Turner, Heidi Schilter, Mandar Deodhar, Wenbin Zhou, Lara Perryman, Jonathan Foot, Amna Zahoor, Yimin Yao, Ross Hamilton, Mary Brock, Christina Raso, Jessica Stolp, Marie Galati, Dieter Hamprecht, Brett Charlton, Wolfgang Jarolimek
An activity-based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti-fibrotic therapeutic strategies. Clinical and translational medicine 11 (11) (2022)
Heidi Schilter, Alison D Findlay, Lara Perryman, Tin T Yow, Joshua Moses, Amna Zahoor, Craig I Turner, Mandar Deodhar, Jonathan S Foot, Wenbin Zhou, Angelique Greco, Amar Joshi, Benjamin S Rayner, Sarah Townsend, Alberto Buson, Wolfgang Jarolimek
The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis. Journal of cellular and molecular medicine 23 (3) (2018)

Heidi Schilter.css-eqlu8i{font-size:small;padding-left:4px;}